Katarína Kollárová (Katarína Vavrová)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 2

Top Topics

Induced Pluripotent Stem Cells

Top Venues

Acta pharmaceutica (Zagreb, Croatia)

This page only lists publications with an associated author ORCID identifier.

Publications

Radek Indra, Sandra Jelínková, Katarína Kollárová, Petra Zahumenská, Josef Dvořák, Šárka Dušková, Helena Dračínská
The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver. Acta pharmaceutica (Zagreb, Croatia) 74 (3) (2024)
Radek Indra, Katarína Kollárová, Petr Pompach, Zbyněk Heger, Petr Hodek
Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b5 Activity. Biomedicines 8 (12) (2020)